Original Research and the Latest News
Recent Posts
7 Small-Cap Biotech Companies to Watch at AACR in April
We anticipate scientific reviews and clinical trial updates from 40 companies on nearly 80 oncology development programs at the...
Recent Tweets
$VSTM Results tomorrow 👀
$VSTM Verastem Oncology Announces Late-Breaking Abstract from Partner GenFleet Therapeutics' Study in China of GFH375 (VS-7375) in Advanced Non-Small Cell Lung Cancer at IASLC 2025 World Conference on Lung Cancer
🚀🚨 BIOPHARM CATALYST ALERT 📆
$NTRA Natera will present Unknown Non-Small-Cell Lung Cancer Data for Signatera (Device - Device) tomorrow 👀
🚀🚨 BIOPHARM CATALYST ALERT 📆
$NUVL Nuvalent will present Phase 1 Non-Small-Cell Lung Cancer Data for Zidesamtinib (ROS1 Inhibitor - Small Molecule) tomorrow 👀
🚀🚨 BIOPHARM CATALYST ALERT 📆
$SMMT Summit will present Phase 3 Non-Small-Cell Lung Cancer Data for Ivonescimab (VEGF Inhibitor,PD-1 Inhibitor - Antibody) tomorrow 👀
Get Started with OZMOSI
We synthesize and process insights, delivering what you need quickly, effectively, and efficiently.
600 Warren Ave,
Spring Lake, NJ 07762